Key Players in the Parkinson’s Disease Treatment Market are Focusing on Product Launches, Expansions, Agreements, and Acquisitions

 The Parkinson’s disease treatment market is projected to reach USD 5.69 Billion by 2022 from an estimated USD 4.24 Billion in 2017, at a CAGR of 6.1%. The major factors driving the growth of this market are Growth in the aging population and the associated increase in the prevalence of Parkinson’s disease and growing government funding and support for research

The Parkinson’s disease treatment market is fragmented in nature due to the presence of a large number of players. The key players are Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), and Boehringer Ingelheim (Germany).

Download PDF Brochure

 @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247

Expansions, acquisitions, agreements, and product launches were the key strategies followed by players in the Parkinson’s disease treatment market. Some of the leading players that adopted this strategy include Teva (Israel), AbbVie (US), Boehringer Ingelheim (Germany) Lundbeck (Denmark), Acadia (US), Sun Pharma (India), US WorldMeds (US), and Dr. Reddy’s (India).

Teva is one of the key players in the Parkinson’s disease treatment market. The company focuses on organic and inorganic strategies to strengthen its position in the Parkinson’s disease treatment market. For instance, in 2015, the company entered into an agreement with Takeda pharmaceutical company to commercialize rasagiline tablets in the Japan.  Moreover, the company received FDA approval for AZILECT drug to treat all stages of the Parkinson’s disease.

Boehringer Ingelheim is another major player in the Parkinson’s disease treatment market. The company mainly focuses on organic strategies to strengthen its position in the market. In 2015, The company launched a new R&D strategy for the fiscal years 2015–2020. The company spends USD 12.2 Billion in R&D to develop new drugs in new medicine for diseases related to oncology, central nervous system, and pulmonary disease areas.

AbbVie is a key player in the Parkinson’s disease treatment market. The company focuses on organic growth to strengthen its positon in the market. For instance, in 2015, the company launched Duopa drug for treating Parkinson’s disease. Moreover, in 2014, the company opened a new manufacturing facility in the Ireland to improve its market presence.

Other important players operating in the market include Impax Laboratories (US), Lundbeck (Denmark), UCB (Belgium), Valeant Pharmaceuticals (Canada), Acadia (US), Sun Pharma (India), Wockhardt (India), Dr. Reddy’s (India), Intas (India), US WorldMeds (US), Zydus Cadila (India), Cipla (India), Strides (India), 1 A Pharma (India), and Upsher-Smith (US). 

Related Reports:

Parkinson's Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Human Microbiome Market Forecast 2025–2031: Driving Healthcare Innovation

Image
  Why the Human Microbiome Matters in 2025 The human microbiome —the trillions of microorganisms living inside the human body—is no longer just a topic for researchers. In 2025, it stands at the center of healthcare innovation , reshaping how we approach precision medicine, gut health, and therapeutic development . From microbiome-based therapies to diagnostics and probiotics, this rapidly expanding sector is capturing the attention of investors, biotech firms, and healthcare providers worldwide . According to the latest market research, the global human microbiome market, valued at US$0.91 billion in 2024, rose to US$1.40 billion in 2025 . It is projected to advance at a remarkable CAGR of 31.0% from 2025 to 2031 , culminating in an estimated US$7.09 billion by 2031 . This explosive growth highlights the increasing relevance of microbiome research in shaping the future of medicine . Download PDF Brochure:  Market Growth Insights & Trends The human microbiome ma...
Read more

Endoscopy Equipment Market Set to Reach USD 53.54 Billion by 2030 | Key Trends, Growth Drivers & Forecast

Image
  The global endoscopy equipment market is on a strong growth trajectory, projected to reach USD 53.54 billion by 2030 , up from USD 37.08 billion in 2025 , registering a CAGR of 7.6% (2025–2030). According to the latest MarketsandMarkets™ report , this surge is fueled by rising demand for minimally invasive procedures , rapid advancements in robot-assisted and AI-integrated endoscopy systems , and increasing day-care and outpatient surgical volumes worldwide. Market Overview: Why Endoscopy Equipment Demand Is Rising The endoscopy devices market has witnessed significant innovation in recent years. Growing cases of gastrointestinal (GI), pulmonary, and urological disorders are driving procedural volumes across hospitals and ambulatory surgical centers (ASCs). Key factors fueling market growth include: Rising patient preference for minimally invasive surgeries (MIS) that reduce pain, hospital stay, and recovery time. Increased adoption of disposable...
Read more

Empty Capsules Market Trends and Competitive Analysis - Exclusive Report by MarketsandMarkets™

Image
  The newly released exclusive study titled "Empty Capsules Market" guarantees that you will be better informed than your competitors. This study provides a comprehensive perspective of the market along with in-depth market insight and analysis that makes survival and success in the market easier. The market report presents the best market and business solutions for the Compound Management industry in this increasingly revolutionary market. Browse and in-depth TOC on "Empty Capsules Market" 176 - Tables 40 - Figures 216 - Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190 According to the new market research report "Empty Capsules Market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period. Some of the Leading Players in the Empty Capsules Market The prominent players operating in the Empty Capsules Market are Capsugel (US), ACG World...
Read more